Company profile for Zentiva

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At present there are 50 markets with a total population of more than a billion people. Zentiva holds leading positions in a number of countries, eg. On markets in the Czech Republic, Romania and Turkey, a pharmaceutical leader. In addition, successfully expanding to other international markets. The key to success is strong and good relations with important trading partners, doctors, pharmacies and patients. Zentiva plans to p...
At present there are 50 markets with a total population of more than a billion people. Zentiva holds leading positions in a number of countries, eg. On markets in the Czech Republic, Romania and Turkey, a pharmaceutical leader. In addition, successfully expanding to other international markets. The key to success is strong and good relations with important trading partners, doctors, pharmacies and patients. Zentiva plans to provide generic products and also provide access to a range of educational and support programs. The product portfolio covers a wide range of major therapeutic areas.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Czech Republic
Address
Address
U kabelovny 529/16, Dolni Mecholupy 102 00 Prague 10
Telephone
Telephone
+420 267 241 111
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/zentiva-appeals-eu-court-decision-on-urban-wastewater-directive-302754396.html

PR NEWSWIRE
27 Apr 2026

https://www.prnewswire.com/news-releases/gtcr-completes-acquisition-of-zentiva-a-leading-european-generics-pharmaceutical-company-302737491.html

PR NEWSWIRE
09 Apr 2026

https://www.prnewswire.com/news-releases/zentiva-publishes-2025-sustainability-report-reinforcing-commitment-to-people-partners-and-the-planet-302714495.html

PR NEWSWIRE
16 Mar 2026

https://www.prnewswire.com/news-releases/zentiva-demands-eulevel-stoptheclock-on-the-uwwtd-to-protect-medicine-availability-302694497.html

PR NEWSWIRE
23 Feb 2026

https://www.prnewswire.com/news-releases/zentiva-expands-into-biologics-with-the-eu-wide-launch-of-its-first-biosimilar-302628251.html

PR NEWSWIRE
01 Dec 2025

https://www.prnewswire.com/news-releases/demonstrating-accountability-zentiva-receives-prestigious-esg-transparency-award-2025-302628149.html

PR NEWSWIRE
28 Nov 2025

USDMF

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow

02

PEGS Boston Summit
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow

02

PEGS Boston Summit
Not Confirmed
arrow

03

Glimepiride

CEP/COS

PEGS Boston Summit
Not Confirmed
arrow

04

Pentoxifylline

CEP/COS

PEGS Boston Summit
Not Confirmed
arrow

05

PEGS Boston Summit
Not Confirmed
arrow

07

PEGS Boston Summit
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

03

PEGS Boston Summit
Not Confirmed
arrow

04

PEGS Boston Summit
Not Confirmed
arrow

05

PEGS Boston Summit
Not Confirmed
arrow

06

PEGS Boston Summit
Not Confirmed
arrow

07

PEGS Boston Summit
Not Confirmed
arrow

09

PEGS Boston Summit
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Registrant Name : Handok Co., Ltd.

Registration Date : 2021-04-16

Registration Number : 20210416-209-J-939

Manufacturer Name : Zentiva Private Limited@BAKUL ...

Manufacturer Address : Plot No. 3501 to 3515, 6301 to 6313 & 16 meter road/c, GIDC Estate, Ankleshwar – 39...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.


Lead Product(s): Methylphenidate Hydrochloride

Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: GTCR

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition April 09, 2026

blank

01

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.

Product Name : Affenid XL

Product Type : Controlled Substance

Upfront Cash : Undisclosed

April 09, 2026

blank

Details:

Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.


Lead Product(s): Phytosterols,Artichoke Extract,Vitamin B1

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Plant Extract/Herbal

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 12, 2026

blank

02

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.

Product Name : Undisclosed

Product Type : Plant Extract/Herbal

Upfront Cash : Inapplicable

February 12, 2026

blank

Details:

An antibody, unconjugated, is showing promising results in treating bone conditions.


Lead Product(s): Undisclosed

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Antibody, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 01, 2025

blank

03

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : An antibody, unconjugated, is showing promising results in treating bone conditions.

Product Name : Undisclosed

Product Type : Antibody, Unconjugated

Upfront Cash : Inapplicable

December 01, 2025

blank

Details:

GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.


Lead Product(s): Methylphenidate Hydrochloride

Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: GTCR

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition September 11, 2025

blank

04

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.

Product Name : Affenid XL

Product Type : Miscellaneous

Upfront Cash : Undisclosed

September 11, 2025

blank

Details:

Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.


Lead Product(s): Methylphenidate Hydrochloride

Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Aurobindo Pharma Limited

Deal Size: $5,500.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition August 20, 2025

blank

05

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.

Product Name : Affenid XL

Product Type : Miscellaneous

Upfront Cash : Undisclosed

August 20, 2025

blank

Details:

Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.


Lead Product(s): Linaprazan Glurate

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Recipient: Cinclus Pharma

Deal Size: $249.2 million Upfront Cash: $14.7 million

Deal Type: Licensing Agreement May 22, 2025

blank

06

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : $14.7 million

May 22, 2025

blank

Details:

Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.


Lead Product(s): Raltegravir Potassium

Therapeutic Area: Infections and Infectious Diseases Brand Name: Raltegravir-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Recipient: Lupin Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 22, 2024

blank

07

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.

Product Name : Raltegravir-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 22, 2024

blank

Details:

Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.


Lead Product(s): Liraglutide

Therapeutic Area: Endocrinology Brand Name: Liraglutide-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Recipient: Biocon

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 28, 2024

blank

08

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.

Product Name : Liraglutide-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

March 28, 2024

blank

Details:

Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.


Lead Product(s): Undisclosed

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Undisclosed

Recipient: Adalvo

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Expanded Collaboration January 09, 2023

blank

09

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Undisclosed

January 09, 2023

blank

Details:

Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.


Lead Product(s): Undisclosed

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Undisclosed

Recipient: Tillomed Laboratories Ltd

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition December 16, 2022

blank

10

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Czech Republic
arrow
PEGS Boston Summit
Not Confirmed

Details : Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Undisclosed

December 16, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Sertralin Zentiva

Dosage Strength : 25mg

Packaging :

Approval Date : 06-10-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Sertralin Zentiva

Dosage Strength : 50mg

Packaging :

Approval Date : 15-05-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Sertralin Zentiva

Dosage Strength : 100mg

Packaging :

Approval Date : 15-05-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Brand Name : Abacavir Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abacavir Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Abacavir Zentiva

Dosage Strength : 300MG

Packaging :

Approval Date : 30-07-2021

Application Number : 86115

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Brand Name : N/A

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : N/A

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name :

Dosage Strength : 600MG; 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Czech Republic

blank

06

Brand Name : Abacavir/Lamivudine ...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abacavir/Lamivudine ...

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Abacavir/Lamivudine Zenti...

Dosage Strength : 600mg;300mg

Packaging :

Approval Date : 07-08-2020

Application Number : 2.02E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

07

Brand Name : Abiraterone Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterone Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film-Coated Tablet

Brand Name : Abiraterone Zentiva

Dosage Strength : 500mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Brand Name : N/A

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : N/A

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name :

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Czech Republic

blank

09

Brand Name : Abiraterona Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterona Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Tablet

Brand Name : Abiraterona Zentiva

Dosage Strength : 250MG

Packaging :

Approval Date : 16-03-2021

Application Number : 85849

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Brand Name : Abiraterona Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterona Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Brand Name : Abiraterona Zentiva

Dosage Strength : 500MG

Packaging :

Approval Date : 16-03-2021

Application Number : 85850

Regulatory Info : Authorized

Registration Country : Spain

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Brand Name : Sertralin Zentiva

Approval Date : 06-10-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 50mg

Packaging :

Brand Name : Sertralin Zentiva

Approval Date : 15-05-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Brand Name : Sertralin Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Sertralin Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Brand Name : Sertralin Zentiva

Approval Date : 15-05-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Brand Name : Abacavir Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abacavir Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 300MG

Packaging :

Brand Name : Abacavir Zentiva

Approval Date : 30-07-2021

Application Number : 86115

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Brand Name : Abacavir/Lamivudine ...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abacavir/Lamivudine ...

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 600mg;300mg

Packaging :

Brand Name : Abacavir/Lamivudine Zentiva

Approval Date : 07-08-2020

Application Number : 2.02E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

06

Brand Name : Abiraterone Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterone Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film-Coated Tablet

Dosage Strength : 500mg

Packaging :

Brand Name : Abiraterone Zentiva

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

Brand Name : Abiraterona Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterona Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Tablet

Dosage Strength : 250MG

Packaging :

Brand Name : Abiraterona Zentiva

Approval Date : 16-03-2021

Application Number : 85849

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Brand Name : Abiraterona Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterona Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 500MG

Packaging :

Brand Name : Abiraterona Zentiva

Approval Date : 16-03-2021

Application Number : 85850

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Brand Name : Abiraterone \"Zentiv...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterone \"Zentiv...

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Brand Name : Abiraterone \"Zentiva\"

Approval Date : 11-07-2022

Application Number : 28106525920

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Brand Name : Abiraterone Zentiva

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Abiraterone Zentiva

arrow
PEGS Boston Summit
Not Confirmed

Zentiva

Dosage Form : Film Coated Tablet

Dosage Strength : 500mg

Packaging :

Brand Name : Abiraterone Zentiva

Approval Date : 21-12-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Zentiva and get a quotation

Zentiva is a supplier offers 19 products (APIs, Excipients or Intermediates).

Find Articaine Hydrochloride bulk with DMF, CEP, WC offered by Zentiva

Find Glibenclamide bulk with DMF, CEP, WC offered by Zentiva

Find Pentoxifylline bulk with CEP, WC offered by Zentiva

Find Tamsulosin bulk with CEP, WC offered by Zentiva

Find Agomelatine bulk with WC offered by Zentiva

Find Glibenclamide bulk with WC offered by Zentiva

Find Pheniramine Maleate bulk with WC offered by Zentiva

Find Piretanide bulk with CEP offered by Zentiva

Find Ramipril bulk with WC offered by Zentiva

Find Rilmenidine Phosphate bulk with CEP offered by Zentiva

Find Tamsulosin bulk with CEP offered by Zentiva

Find Tenofovir Alafenamide bulk with WC offered by Zentiva

Find Carvedilol bulk offered by Zentiva

Find Glimepiride bulk offered by Zentiva

Find Metipranolol HCl bulk offered by Zentiva

Find Metoprolol Succinate bulk offered by Zentiva

Find Tetrahydrozoline bulk offered by Zentiva

Find Tramadol Hydrochloride bulk offered by Zentiva

Find Zolpidem Tartrate bulk offered by Zentiva

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty